Strata Critical Medical
SRTA
99 hedge funds and large institutions have $156M invested in Strata Critical Medical in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 35 reducing their positions, and 8 closing their positions.
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
3% more funds holding
Funds holding: 96 → 99 (+3)
9% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $1.8M
1.14% less ownership
Funds ownership: 55.36% → 54.22% (-1.1%)
37% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 35
39% less capital inflows, than outflows
Capital inflows: $5.72M | Capital outflows: $9.36M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$2.71M |
| 2 |
Deane Retirement Strategies
New Orleans,
Louisiana
|
+$671K |
| 3 |
Ionic Capital Management
New York
|
+$302K |
| 4 |
Millennium Management
New York
|
+$284K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$258K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$3.11M |
| 2 |
ARK Investment Management
St. Petersburg,
Florida
|
-$2.64M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$883K |
| 4 |
Cantor Fitzgerald
New York
|
-$745K |
| 5 |
Nikko Asset Management Americas
New York
|
-$276K |
SRTA Hedge Fund Activity: Q3 2022 in Review
99 of the 5,834 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical (SRTA) for Q3 2022, worth a combined $156M — down 20% from $195M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new SRTA positions and 8 closed out — a net gain of 4 holders — while 22 added to existing stakes and 35 trimmed.
The largest buyer was Brandywine Global Investment Management, opening a new position worth an estimated $2.71M. The largest seller was State Street, cutting an estimated $3.11M.
- 99 institutional investors held Strata Critical Medical (SRTA) as of Q3 2022, up from 96 in Q2 2022.
- Funds reported $156M of Strata Critical Medical stock for Q3 2022, down 20% quarter-over-quarter.
- 12 funds opened new Strata Critical Medical positions in Q3 2022 and 8 closed out, a net change of +4 holders.
- The largest Strata Critical Medical buyer in Q3 2022 was Brandywine Global Investment Management, an estimated $2.71M added.
- The largest Strata Critical Medical seller in Q3 2022 was State Street, an estimated $3.11M sold.
Based on aggregated 13F filings for Q3 2022.